Clinical Trial Update: Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study. [Phase 4]

View source ↗

Summary

A noncontrolled, prospective pilot Phase 4 trial is studying nemolizumab for lichen planopilaris and is currently recruiting. The study assesses the use of nemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lichen Planopilaris

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: The Skin Center Dermatology Group | Conditions: Lichen Plano-Pilaris | Phase 4 | Status: RECRUITING